Boren T - Search Results

1

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, Kamath S, Chen DT, Dressman H, Lancaster JM. Boren T, et al. Gynecol Oncol. 2008 Aug;110(2):206-15. doi: 10.1016/j.ygyno.2008.03.023. Epub 2008 May 21. Gynecol Oncol. 2008. PMID: 18499237

2

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy.

Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Kamath SG, Chen DT, Dressman H, Lancaster JM. Boren T, et al. Gynecol Oncol. 2009 May;113(2):249-55. doi: 10.1016/j.ygyno.2009.01.014. Epub 2009 Feb 23. Gynecol Oncol. 2009. PMID: 19237188

3

Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin.

Indermaur MD, Xiong Y, Kamath SG, Boren T, Hakam A, Wenham RM, Apte SM, Lancaster JM. Indermaur MD, et al. Among authors: boren t. Am J Obstet Gynecol. 2010 Aug;203(2):158.e1-40. doi: 10.1016/j.ajog.2010.02.003. Epub 2010 May 4. Am J Obstet Gynecol. 2010. PMID: 20444440

4

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.

Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, Lancaster JM. Berchuck A, et al. Among authors: boren t. Clin Cancer Res. 2009 Apr 1;15(7):2448-55. doi: 10.1158/1078-0432.CCR-08-2430. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318476 Free PMC article.

5

Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.

Boren T, Lea J, Kehoe S, Miller DS, Richardson D. Boren T, et al. Gynecol Oncol. 2012 Oct;127(1):43-6. doi: 10.1016/j.ygyno.2012.06.018. Epub 2012 Jun 16. Gynecol Oncol. 2012. PMID: 22713294

6

Correlation of cone biopsy with findings at radical hysterectomy and use of adjuvant radiation therapy.

Boren TP, Carrick K, Kehoe SM, Lea J, Miller DS, Richardson DL. Boren TP, et al. Gynecol Oncol. 2012 Mar;124(3):508-11. doi: 10.1016/j.ygyno.2011.11.014. Epub 2011 Nov 19. Gynecol Oncol. 2012. PMID: 22108254

7

Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?

Boren TP, Miller DS. Boren TP, et al. Womens Health (Lond). 2010 Nov;6(6):789-95. doi: 10.2217/whe.10.64. Womens Health (Lond). 2010. PMID: 21118038 Free article.

8

Sparse feature selection for classification and prediction of metastasis in endometrial cancer.

Ahsen ME, Boren TP, Singh NK, Misganaw B, Mutch DG, Moore KN, Backes FJ, McCourt CK, Lea JS, Miller DS, White MA, Vidyasagar M. Ahsen ME, et al. BMC Genomics. 2017 Mar 27;18(Suppl 3):233. doi: 10.1186/s12864-017-3604-y. BMC Genomics. 2017. PMID: 28361685 Free PMC article.

9

Somatic LKB1 mutations promote cervical cancer progression.

Wingo SN, Gallardo TD, Akbay EA, Liang MC, Contreras CM, Boren T, Shimamura T, Miller DS, Sharpless NE, Bardeesy N, Kwiatkowski DJ, Schorge JO, Wong KK, Castrillon DH. Wingo SN, et al. Among authors: boren t. PLoS One. 2009;4(4):e5137. doi: 10.1371/journal.pone.0005137. Epub 2009 Apr 2. PLoS One. 2009. PMID: 19340305 Free PMC article.

10

An update on endometrial cancer.

Boren T, Miller D. Boren T, et al. Tex Med. 2010 Sep 1;106(9):50-5. Tex Med. 2010. PMID: 20809444 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page